Our data suggested that GARP expression was increased in the Tregs from tumor tissues of patients with lung cancer and the proportion of GARP-expressing Tregs was obviously higher in lung cancer patients without lymph node metastasis or distant metastasis and in patients with early clinical stage. This evidence concerns the gene LRRC32 and lung cancer.